Recce Pharmaceuticals (ASX:RCE) rockets to record high on COVID-19 update

The Recce Pharmaceuticals Ltd (ASX:RCE) share price is rocketing higher today after revealing a positive update on its COVID-19 testing…

| More on:
digital stock graph against backdrop of world map and covid bugs

Image source: Getty Images

The Recce Pharmaceuticals Ltd (ASX: RCE) share price has returned from its trading halt on Tuesday and is shooting higher.

In afternoon trade the biotechnology company’s shares rocketed as much as 27% higher to a record high of $1.87 at one stage.

They have since dropped back a touch but are still up 10.5% to $1.63 at the time of writing.

Why is the Recce share price rocketing higher?

Investors have been buying Recce’s shares after it provided an update on the international SARS-CoV-2 (COVID-19) in vitro studies undertaken by Path BioAnalytics and the University of Tennessee’s Health Science Centre.

According to the release, Recce 327 (R327) and Recce 529 (R529) compounds have shown concentration-dependent reductions in the COVID-19 virus in an in-vitro study using organoids made from human airway epithelial cells.

Management also advised that the concentrations of R327 and R529 further indicated an excellent toxicity profile (<0.25%) on Vero (monkey) cells, in a separate but related study.

In light of these results, the researchers have recommended that the company should advance research of both R327 and R529. To do so, it has secured testing of the compounds in a gold-standard in-vivo COVID-19 infection study in ferrets. This US ferret study is expected to begin this month and be completed prior to the end of 2020.

Non-Executive Chairman Dr John Prendergast said: “We are very pleased with the anti-viral activity against SARS-CoV-2 demonstrated by our two compounds, RECCE 327 and RECCE 529 in vitro, and look forward to further success in the forthcoming ferret model studies. As COVID-19 infections and mortalities continue to rise, an effective treatment is critical. Recce’s anti-infective technology is striving to address the global health problem of emerging viral pathogens.”

Though, the company warned investors not get too excited just yet.  It explained: “Whilst Recce is delighted by the results, further testing must be completed before either (or both) compounds may be deemed safe or effective as a treatment of SARS-CoV-2.”

In other news.

Recce isn’t the only junior biotech company that is hoping to develop compounds to fight COVID-19.

On Monday, the Biotron Limited (ASX: BIT) share price rocketed higher after providing an update on the screening of select compounds against COVID-19.

According to the release, Biotron has concluded the first stage of its screenings and found that several compounds have been shown in laboratory cell-culture studies to have antiviral activity against COVID-19.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

*Returns as of 15/2/2021

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Share Gainers

Why Beach, Jumbo, Premier Investments, and Western Areas are pushing higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another disappointing decline. At the time of …

Read more »

A man in a blue collared shirt sits at his desk doing a single fist pump as he watches his Neometals shares rising on his laptop
Resources Shares

Why is the BHP (ASX:BHP) share price leaping ahead today?

The S&P/ASX 200 Index (ASX: XJO) has unfortunately slipped into negative territory so far this Thursday, after an initially strong market …

Read more »

Businessman in suit and holding a briefcase jumps into the sky celebrating the rising Enero share price
Share Gainers

‘Exclusive provider’: Genworth (ASX:GMA) share price leaps 12% on CBA deal

Key points Genworth is cruising today following a company announcement The company has been selected as the exclusive provider of …

Read more »

A group of people cheer at a blackjack table in a casino
Share Gainers

Why the PointsBet (ASX:PBH) share price is rocketing 9% today

Key points The online gambling market continues to grow West Virginia becomes the third US state to host PointsBet’s online …

Read more »

Rising share price chart.
Share Gainers

Why A2 Milk, Baby Bunting, Codan, and Sezzle shares are surging higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another very disappointing decline. At the time of …

Read more »

Three excited business people cheer around a laptop in the office
Share Gainers

Why Corporate Travel Management, Goodman, Lendlease, and Uniti shares are rising today

The S&P/ASX 200 Index (ASX: XJO) is out of form again on Monday. In afternoon trade, the benchmark index is down 0.5% …

Read more »

A man wearing glasses sits back in his desk chair with his hands behind his head staring smiling at his computer screens as the ASX share prices keep rising
Share Gainers

Why is the Uniti (ASX:UWL) share price up 10% on Monday?

Key points The Uniti share price is trading 10% higher today following its latest update Multiple approaches have been made …

Read more »

A man and woman put hands in the air as they dance in front of a green brick wall.
Share Gainers

These were the best performing ASX 200 shares last week

It certainly was a week to forget for the S&P/ASX 200 Index (ASX: XJO). A major selloff on Friday led to …

Read more »